Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Beachhead Reports

The Future of Genomic Research Emerging Markets and Applications for Microarray Technology
Microarrays for gene expression have made a profound impact in the biomedical world. The next obvious step is to go beyond gene expression and utilize microarray technology to enable whole ‘ome’ analysis for a variety of other applications, such as genotyping, comparative genomic hybridization, splice variants, ChIP arrays, and resequencing.

Beyond Expression Arrays Emerging Applications for Genomic Microarray Technology
This report assess the challenges and future prospects for many of the new applications driving the microarray industry beyond expression arrays. Based on in-depth interviews with industry thought leaders, we present a close look at the biological and market drivers for applications such as SNPs, resequencing, ChIP/Chip, DNA methylation and splice variant arrays. Competitive technologies to microarrays are discussed in terms of their impact on market adoption of array-based technologies. Detailed and insightful qualitative assessments for market adoption, as well as quantitative analyses of current and future market sizing are presented throughout. The business and scientific communities alike are given critical guidance and information around the potential of these exciting new applications.

Synthetic Biology: A New Paradigm for Biological Discovery
The late Richard P. Feynman, a Nobel laureate in physics, professor of theoretical physics at the California Institute of Technology, and a member of the team that developed the first atomic bomb, left an epigram on the blackboard of his office which sums up the conundrum of synthetic biology: “What I cannot create, I cannot understand.” Synthetic biology can be described as both the design and fabrication of biological components and systems that do not exist in the natural world and the re-design and fabrication of existing biological systems.By combining expertise in the fields of biochemistry, biophysics, molecular biology, engineering and organic chemistry, synthetic biology can be utilized to manufacture existing biological pieces into machines and create artificial systems that reproduce properties of living systems. By creating systems that mimic what nature has created, such as the interactions between proteins and genes, scientists can discover the basic principles that rule living systems. They can then apply that knowledge for untold purposes, from creating new medicines to solving the world’s energy crisis to discovering life on other planets.

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions